Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Sonocloud-9 with Carboplatin versus standard chemotherapy (lomustine or temozolomide) for recurrent glioblastoma; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • Lomustine (CCNU) (lomustine)
  • Sonocloud-9
  • Temozolomide (TMZ) (temozolomide)

Snippet

Sponsor: CarThera | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 3 | Status: RECRUITING